scispace - formally typeset
Open AccessJournal Article

A dot enzyme immunoassay for dengue 3 virus: comparison with the haemagglutination inhibition test.

Reads0
Chats0
TLDR
The data suggest that it is possible to use a single dilution as a cutoff point to predict with reasonable accuracy, if a patient has had a recent dengue infection.
Abstract
A dot enzyme immunoassay (DEIA) was used to determine the levels of antibody to dengue 3 virus in the acute and convalescent sera of febrile patients with a clinical diagnosis of dengue fever or dengue haemorrhagic fever. The antibody titres were compared with titres determined by the haemagglutination inhibition (HI) test. The results of the study showed that, besides being more simple to perform, the DEIA is in order of magnitude more sensitive than the HI test. Furthermore, the data suggest that it is possible to use a single dilution as a cutoff point to predict with reasonable accuracy, if a patient has had a recent dengue infection. The DEIA test for antibodies to dengue virus is an appropriate technology highly suitable for rapid diagnosis and surveillance in developing countries.

read more

Citations
More filters
Journal ArticleDOI

Dengue in the western hemisphere

TL;DR: There is no specific treatment for dengue; hydration is important as well as aggressive fluid management if hypotension develops, and it is important to avoid aspirin and salicylates.
Journal ArticleDOI

Multicentre evaluation of dengue IgM dot enzyme immunoassay

TL;DR: A new, commercial nitrocellulose membrane based IgM capture enzyme immunoassay has a role to play in the diagnosis of dengue infection, especially in peripheral health settings.

Dengue fever, dhf and dss

Consultant, +1 more
TL;DR: A small subset of patients with DHF will develop features of circulatory collapse, the DSS – dengue shock syndrome which has a high case fatality rate and is now increasingly diagnosed in the Indian subcontinent.
Related Papers (5)